Browse medicines, page 28 of 37

Use listed on the medicine record

Short-term adjunctive therapy

Use listed on the medicine record

Schizophrenia

Use listed on the medicine record

Malaria

Use listed on the medicine record

The treatment of adult patients

Use listed on the medicine record

INDICATIONS ANDUSAGE Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Use listed on the medicine record

Topical treatment of the inflammatory papules and pustules of mild to moderate rosacea

Use listed on the medicine record

The management of severe spasticity

Use listed on the medicine record

Latent, extra-pulmonary or drug-sensitive TB or for the treatment of infections caused by non-tuberculous mycobacteria

Use listed on the medicine record

● helps prevent sunburn ● if used as directed with other sun protection measures ( see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Use listed on the medicine record

Helps prevent gingivitis, an early form of gum disease, and bleeding gums Helps control plaque that leads to gingivitis and bleeding gums Directions Adults and children 12 years of age and older: Vigorously swish 20 mL (4 teaspoonfuls) of rinse between your teeth twice a day for 30 seconds and then spit out. Do not swallow the rinse. Children 6 years to under 12 years: Supervise use. Children under 6 years of age: Do not use.

Use listed on the medicine record

Cisatracurium Besylate Injection is indicated: • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age • to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU • to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older Cisatracurium Besylate Injection is a nondepolarizing neuromuscular blocker indicated: • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in…

Use listed on the medicine record

For use with 3-pump hemodialysisi machines only, using purified water (StandardUNE-EN ISO 23500-3:2019).

Use listed on the medicine record

The topical treatment of acne vulgaris

Use listed on the medicine record

Pediatric patients 1 to 21 years old with relapsed or refractory acute lymphoblastic leukemia after at least two prior regimens

Use listed on the medicine record

Systemic exposure of atazanavir or darunavir

Use listed on the medicine record

Superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics

Use listed on the medicine record

Symptomatic relief of non-infectious diarrhea

Use listed on the medicine record

Cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. Like all antituberculosis drugs, cycloserine should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent.

Use listed on the medicine record

Perennial and seasonal allergic rhinitis, Vasomotor rhinitis, Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Amelioration of allergic reactions to blood or plasma. Cold urticaria. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Use listed on the medicine record

Wilms tumor, as part of a multi-phase, combination chemotherapy regimen

Use listed on the medicine record

Severe hypoglycemia

Use listed on the medicine record

Decitabine for Injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.

Use listed on the medicine record

KRAS -mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy

Use listed on the medicine record

Treatment of infections caused by the following gram-negative microorganisms, when bacteriologic testing indicates appropriate susceptibilit

Use listed on the medicine record

Mild to moderate atopic dermatitis

Use listed on the medicine record

Plaque psoriasis

Use listed on the medicine record

Major depressive disorder (MDD) [see Clinical Studies (14) and Dosage and Administration (2

Use listed on the medicine record

Cystic fibrosis

Use listed on the medicine record

Temporarily relieves these symptoms due to hay fever (allergic rhinitis) or upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes

Use listed on the medicine record

For temporary relief of local discomfort, itching, pain, soreness, or burning associated with minor skin procedure.

Use listed on the medicine record

To reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules and other antibacterial drugs, dicloxacillin sodium capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Use listed on the medicine record

Functional bowel/irritable bowel syndrome

Use listed on the medicine record

for relief of: bloating pressure fullness stuffed feeling commonly referred to as gas

Use listed on the medicine record

INDICATIONS & USAGE Dipyridamole Injection is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. In a study of about 1100 patients who underwent coronary arteriography and Dipyridamole Injection assisted thallium imaging, the results of both tests were interpreted blindly and the sensitivity and specificity of the dipyridamole thallium study in predicting the angiographic outcome were calculated.

Use listed on the medicine record

Acute lymphoblastic leukemia acute myeloblastic leukemia Hodgkin lymphoma non-Hodgkin lymphoma (NHL) metastatic breast cancer metastatic Wil

Use listed on the medicine record

Cluster headache

Use listed on the medicine record

Moderate to severe vasomotor symptoms (VMS) due to menopause

Use listed on the medicine record

Relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by

Use listed on the medicine record

Ergomar ® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called "histaminic cephalalgia".

Use listed on the medicine record

INDICATIONS & USAGE Estazolam is indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see CLINICAL PHARMACOLOGY ). Because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended.